Faruqi & Faruqi, LLP Investigating Potential Claims Against Zeta Global Holdings Corp. Following Release of Culper Research Report

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSE: ZETA).

Faruqi & Faruqi, LLP is investigating potential claims against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSE: ZETA) on behalf of investors who purchased Zeta common stock between March 13, 2024 and November 13, 2024, inclusive (the “Class Period”).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

On November 13, 2024, Culper Research released a report alleging that Zeta, a data-driven marketing and advertising technology company, engages in deceptive data collection practices. The report claims that Zeta uses “consent farms”—websites that gather consumer data through misleading tactics—and highlights Zeta's undisclosed “two-way” contracts with third-party data providers, raising concerns about potential round-tripping.

Block & Leviton is investigating these claims.

On this news, Zeta's common stock fell $10.48 per share, or 37.14%, to close at $17.74 per share on November 13, 2024.

If you wish to discuss this investigation or have any questions concerning this notice or your rights or interests, please contact Josh Wilson, Faruqi & Faruqi partner, by email at jwilson@faruqilaw.com, by telephone at 877-247-4292, or by mail at Faruqi & Faruqi, LLP, 369 Lexington Avenue, Suite 1050, New York, NY 10017.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.